AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UroGen Pharma Ltd. Director's Dealing 2021

Jun 9, 2021

Director's Dealing

Opens in your device viewer

Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2021-03-25

Reporting Person: Nussbaum Ran (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-25	Ordinary Shares	M	1030	$5.00	Acquired	1431717	Indirect

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-25	Stock Option (right to buy)	$5.00	M	1030	Disposed	2021-07-27	Ordinary Shares (1030)	Indirect

F1: On April 22, 2021, the reporting person filed a Form 4 that mistakenly listed the transaction date as March 24, 2021.